Search
for

    Research 10 of 105

    1. Alopecia Areata: Current and Emerging Therapies Drugs · 2026
    2. Quantitative and qualitative analysis of individual experiences post botulinum toxin injection ‐ United Kingdom Survey Skin health and disease · 2023
    3. The Burden of Alopecia Areata and Management with Baricitinib in the United Arab Emirates: A Narrative Review Dermatology and Therapy · 2025
    4. Industry updates in advanced therapy medicinal products and regenerative medicine – March 2026 Regenerative Medicine · 2026
    5. Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review 2025 · 1 citations
    6. Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024 Pharmaceuticals · 2025 · 8 citations
    7. Spironolactone May Reduce the Risk of Incident Rosacea Journal of Investigative Dermatology · 2013 · 6 citations
    8. The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis Frontiers in Immunology · 2025 · 1 citations
    9. Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database Frontiers in Immunology · 2026
    10. The Current Landscape for Direct-to-Consumer Genetic Testing: Legal, Ethical, and Policy Issues Annual Review of Genomics and Human Genetics · 2008 · 244 citations
    All research results →

    Learn 2 of 3

    1. Finasteride Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically
    2. Dutasteride 5-alpha reductase inhibitor that blocks both enzyme types, a stronger DHT blocker than finasteride
    All learn results →

    Community

    — no results

    Try a deeper search in community →